Collaborative Islet Transplant Registry Data Collection.
â
Funded by EMMS/NIH.
CLOSED
ENROLLMENT
A phase 2/3, multicenter, randomized, double blind, placebo-controlled, parallel assignment Study to assess the Efficacy and Safety of Reparixin in pancreatic islet auto-transplantation (REP0112).